Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Dehydroabiethylamine (NSC-2955) is an inducer of hepatic CYP2B activity. Dehydroabiethylamine inhibits pyruvate dehydrogenase kinases (PDKs) and intracellular cholesterol transport with anti-tumor activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
500 mg | In stock | $ 39.00 | |
1 g | In stock | $ 55.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 39.00 |
Description | Dehydroabiethylamine (NSC-2955) is an inducer of hepatic CYP2B activity. Dehydroabiethylamine inhibits pyruvate dehydrogenase kinases (PDKs) and intracellular cholesterol transport with anti-tumor activity. |
Synonyms | NSC-2955, NSC 2955, Dehydroabietylamine, NSC2955, Leelamine free base, Leelamine |
Molecular Weight | 285.47 |
Formula | C20H31N |
CAS No. | 1446-61-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 25 mg/mL (87.57 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Dehydroabiethylamine 1446-61-3 Metabolism PI3K/Akt/mTOR signaling PDK P450 Pyruvate dehydrogenase kinase PDH kinase Inhibitor PDHK NSC-2955 NSC 2955 Dehydroabietylamine NSC2955 Cannabinoid Receptor Leelamine free base Leelamine inhibit inhibitor